Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitis.

Hajir IbraheimSamantha BaillieMark A SamaanHamzah Abu-SbeihYinghong Wang Nicholas J TalleyMichael P JonesNicholas Powell

Published in: Alimentary pharmacology & therapeutics (2020)

Corticosteroids, infliximab and vedolizumab, are effective in the treatment of checkpoint inhibitor-induced enterocolitis. Checkpoint inhibitor regimen and cancer type were significant moderators in response to corticosteroid therapy.

Keyphrases

dna damage
high glucose
diabetic rats
anti inflammatory
cell cycle
randomized controlled trial
drug induced
systematic review
low birth weight
oxidative stress
squamous cell carcinoma
stem cells
cell proliferation
patients with inflammatory bowel disease
replacement therapy